| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.04B | +17.3% |
| Gross profit | ¥0.18B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | -124.7% |
| Gross margin | 17.0% | Net margin -1.2% |
| Revenue Q/Q | -3.1% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.86B | 83.0% |
| R&D | ¥0.08B | 7.9% |
| SG&A | ¥0.07B | 7.0% |
| Tax & other | ¥0.00B | 0.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
回盛生物 ・ 天阳科技 ・ 海晨股份 ・ 捷强装备 ・ 蒙泰高新 ・ 金春股份 ・ 维康药业 ・ 大叶股份 ・ 迦南智能 ・ 盛德鑫泰 ・ 万胜智能 ・ 龙利得
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies